Status:
COMPLETED
A Safety Tolerance and Experimental Hyperalgesia Study of Oral NGX426 in Healthy Male Voluneteers
Lead Sponsor:
TorreyPines Therapeutics
Conditions:
Healthy
Hyperalgesia
Eligibility:
MALE
21-55 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to determine the effects of NGX426 on intradermal capsaicin induced pain in hyperalgesia.
Eligibility Criteria
Inclusion
- Healthy males, age 21-55
Exclusion
- Allergy to study drug
Key Trial Info
Start Date :
May 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2008
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT00832546
Start Date
May 1 2008
End Date
September 1 2008
Last Update
January 30 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California
San Diego, California, United States, 92037